# Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US

> **NCT06018571** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 946 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06018571
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-02
- **Primary completion:** 2022-08-19
- **Final completion:** 2022-08-19
- **Target enrollment:** 946 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06018571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06018571, "Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06018571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*